MedPath

Blood Pressure Changes After Bariatric Surgery

Recruiting
Conditions
Blood Pressure
Bariatric Surgery
Obesity
Hypertension
Interventions
Procedure: Bariatric surgery - sleeve gastrectomy
Registration Number
NCT06460233
Lead Sponsor
Medical University of Warsaw
Brief Summary

The aim of the study is to assess changes in blood pressure, cardiac function and selected laboratory measurements after bariatric surgery and to find most important factors associated with blood pressure reduction after weight loss.

Description of the study

Patients: consecutive patients with class III obesity (BMI ≥ 40kg/m2) or class II obesity (BMI 35-40kg/m2) with comorbidities, admitted for sleeve gastrectomy

Methods: bedside and 24-hour blood pressure measurement, cardiac ultrasound and laboratory tests performed before surgery and at 1 week, 4 weeks, 6 months and 12 months after bariatric surgery

Detailed Description

Pathogenesis of blood pressure reduction associated with weight loss is not established. We hypothesize that monitoring of blood pressure changes after weight loss, with concomitant evaluation of cardiac output and selected biochemical parameters related to blood pressure regulation may help in the understanding of weight loss-associated decrease in blood pressure.

The study protocol include measurement of blood pressure (bedside and 24h blood pressure monitoring), assessment of the cardiac function and biochemistry 1-2 days before laparoscopic sleeve gastrectomy and at the time of routine surgical follow-up visits after surgery ie. one week, one month, six and twelve months. Blood pressure measurements will be performed using automatic oscillometric monitors (OnTrak , Spacelabs,USA). Cardiac evaluation will include an echocardiographic assessment of the systolic and diastolic left ventricular function as well as cardiac output measurement using Doppler method. Biochemistry measures, in addition to routine blood tests needed for surgical follow-up, will include fasting insulin, high sensivity C-reactive protein, cystatin C, and NT-proBNP.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • BMI ≥40kg/m2 or ≥35 kg/m2 with comorbidities
Exclusion Criteria
  • Lack of informed consent
  • Expected lack of compliance
  • Psychiatric illness
  • Previous bariatric surgery
  • Severe gastroesophageal reflux disease
  • Active neoplastic disease
  • Pregnancy
  • Chronic atrial fibrillation or other persistent arrhythmia

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients with class III obesity (BMI ≥ 40) or class II obesity (BMI 35-40) with comorbiditiesBariatric surgery - sleeve gastrectomyConsecutive patients with class III obesity (BMI ≥ 40kg/m2) or class II obesity (BMI 35-40kg/m2) with comorbidities admitted for bariatric surgery (sleeve gastrectomy)
Primary Outcome Measures
NameTimeMethod
Change from baseline in the 24-hour blood pressure at one week after bariatric surgery (sleeve gastrectomy)1-2 days before and 7 to 10 days after surgery

Mean systolic and diastolic blood pressure in mmHg, measured using 24 hour ambulatory blood pressure monitor

Secondary Outcome Measures
NameTimeMethod
Change from baseline in bedside blood pressure at one month after bariatric surgery1-2 days before and 28 to 31 days after surgery

Systolic and diastolic blood pressure in mmHg, averaged from two measurements using automatic blood pressure monitor, performed in supine position at the end of echocardiographic study

Change from baseline in the left ventricular systolic function at six months after bariatric surgery1-2 days before and 5 to 7 months after bariatric surgery

Echocardiographic measurement of the lateral and medial mitral annulus peak systolic velocities in meters per second, using tissue Doppler method

Change from baseline in serum fasting insulin level at one year after bariatric surgery1-2 days before and 11 to 13 months after bariatric surgery

Laboratory measurement of serum fasting insulin level in µIU/ml

Change from baseline in serum Cystatin C level at one year after bariatric surgery1-2 days before and 11 to 13 months after bariatric surgery

Laboratory measurement of serum Cystatin C level in mg/l

Change from baseline in serum NT-proBNP level at one week after bariatric surgery1-2 days before and 7 to 10 days after bariatric surgery

Laboratory measurement of serum NT-proBNP level in pg/ml

Change from baseline in bedside blood pressure at six months after bariatric surgery1-2 days before and 5 to 7 months after surgery

Systolic and diastolic blood pressure in mmHg, averaged from two measurements using automatic blood pressure monitor, performed in supine position at the end of echocardiographic study

Change from baseline in cardiac output at six months after bariatric surgery1-2 days before and 5 to 7 months after surgery

Echocardiographic measurement of cardiac output in liters per minute using Doppler method

Change from baseline in the left ventricular diastolic function at one month after bariatric surgery1-2 days before and 28 to 31 days after bariatric surgery

Echocardiographic measurement of the lateral and medial mitral annulus peak early diastolic velocities in meters per second, using tissue Doppler method, and of the early and late mitral inflow peak velocities in meters per second, using pulse wave Doppler method

Change from baseline in serum fasting insulin level at one week after bariatric surgery1-2 days before and 7 to 10 days after bariatric surgery

Laboratory measurement of serum fasting insulin level in µIU/ml

Change from baseline in serum high- sensivity C-Reactive Protein level at one week after bariatric surgery1-2 days before and 7 to 10 days after bariatric surgery

Laboratory measurement of serum high- sensivity C-Reactive Protein level in mg/l

Change from baseline in serum high- sensivity C-Reactive Protein level at one month after bariatric surgery1-2 days before and 28 to 31 days after bariatric surgery

Laboratory measurement of serum high- sensivity C-Reactive Protein level in mg/l

Change from baseline in serum high- sensivity C-Reactive Protein level at one year after bariatric surgery1-2 days before and 11 to 13 months after bariatric surgery

Laboratory measurement of serum high- sensivity C-Reactive Protein level in mg/l

Change from baseline in serum Cystatin C level at six months after bariatric surgery1-2 days before and 5 to 7 months after bariatric surgery

Laboratory measurement of serum Cystatin C level in mg/l

Change from baseline in serum NT-proBNP level at six months after bariatric surgery1-2 days before and 5 to 7 months after bariatric surgery

Laboratory measurement of serum NT-proBNP level in pg/ml

Change from baseline in cardiac output at one year after bariatric surgery1-2 days before and 11 to 13 months after surgery

Echocardiographic measurement of cardiac output in liters per minute using Doppler method

Change from baseline in the 24-hour blood pressure at six months after bariatric surgery (sleeve gastrectomy)1-2 days before and 5 to 7 months after surgery

Mean systolic and diastolic blood pressure in mmHg, measured using 24 hour ambulatory blood pressure monitor

Change from baseline in the left ventricular systolic function at one week after bariatric surgery1-2 days before and 7 to 10 days after bariatric surgery

Echocardiographic measurement of the lateral and medial mitral annulus peak systolic velocities in meters per second, using tissue Doppler method

Change from baseline in the left ventricular diastolic function at six months after bariatric surgery1-2 days before and 5 to 7 months after bariatric surgery

Echocardiographic measurement of the lateral and medial mitral annulus peak early diastolic velocities in meters per second, using tissue Doppler method, and of the early and late mitral inflow peak velocities in meters per second, using pulse wave Doppler method

Change from baseline in the left ventricular diastolic function at one year after bariatric surgery1-2 days before and 11 to 13 months after bariatric surgery

Echocardiographic measurement of the lateral and medial mitral annulus peak early diastolic velocities in meters per second, using tissue Doppler method, and of the early and late mitral inflow peak velocities in meters per second, using pulse wave Doppler method

Change from baseline in serum fasting insulin level at six months after bariatric surgery1-2 days before and 5 to 7 months after bariatric surgery

Laboratory measurement of serum fasting insulin level in µIU/ml

Change from baseline in serum high- sensivity C-Reactive Protein level at six months after bariatric surgery1-2 days before and 5 to 7 months after bariatric surgery

Laboratory measurement of serum high- sensivity C-Reactive Protein level in mg/l

Change from baseline in serum Cystatin C level at one month after bariatric surgery1-2 days before and 28 to 31 days after bariatric surgery

Laboratory measurement of serum Cystatin C level in mg/l

Change from baseline in bedside blood pressure at one week after bariatric surgery1-2 days before and 7 to 10 days after surgery

Systolic and diastolic blood pressure in mmHg, averaged from two measurements using automatic blood pressure monitor, performed in supine position at the end of echocardiographic study

Change from baseline in the 24-hour blood pressure at one month after bariatric surgery (sleeve gastrectomy)1-2 days before and 28 to 31 days after surgery

Mean systolic and diastolic blood pressure in mmHg, measured using 24 hour ambulatory blood pressure monitor

Change from baseline in the 24-hour blood pressure at one year after bariatric surgery (sleeve gastrectomy)1-2 days before and 11 to 13 months after surgery

Mean systolic and diastolic blood pressure in mmHg measured using 24 hour ambulatory blood pressure monitor

Change from baseline in the left ventricular diastolic function at one week after bariatric surgery1-2 days before and 7 to 10 days after bariatric surgery

Echocardiographic measurement of the lateral and medial mitral annulus peak early diastolic velocities in meters per second, using tissue Doppler method, and of the early and late mitral inflow peak velocities in meters per second, using pulse wave Doppler method

Change from baseline in serum fasting insulin level at one month after bariatric surgery1-2 days before and 28 to 31 days after bariatric surgery

Laboratory measurement of serum fasting insulin level in µIU/ml

Change from baseline in serum NT-proBNP level at one year after bariatric surgery1-2 days before and 11 to 13 months after bariatric surgery

Laboratory measurement of serum NT-proBNP level in pg/ml

Change from baseline in bedside blood pressure at one year after bariatric surgery1-2 days before and 11 to 13 months after surgery

Systolic and diastolic blood pressure in mmHg, averaged from two measurements using automatic blood pressure monitor, performed in supine position at the end of echocardiographic study

Change from baseline in cardiac output at one week after bariatric surgery1-2 days before and 7 to 10 days after surgery

Echocardiographic measurement of cardiac output in liters per minute using Doppler method

Change from baseline in cardiac output at one month after bariatric surgery1-2 days before and 28 to 31 days after surgery

Echocardiographic measurement of cardiac output in liters per minute using Doppler method

Change from baseline in the left ventricular systolic function at one month after bariatric surgery1-2 days before and 28 to 31 days after bariatric surgery

Echocardiographic measurement of the lateral and medial mitral annulus peak systolic velocities in meters per second, using tissue Doppler method

Change from baseline in the left ventricular systolic function at one year after bariatric surgery1-2 days before and 11 to 13 months after bariatric surgery

Echocardiographic measurement of the lateral and medial mitral annulus peak systolic velocities in meters per second, using tissue Doppler method

Change from baseline in serum Cystatin C level at one week after bariatric surgery1-2 days before and 7 to 10 days after bariatric surgery

Laboratory measurement of serum Cystatin C level in mg/l

Change from baseline in serum NT-proBNP level at one month after bariatric surgery1-2 days before and 28 to 31 days after bariatric surgery

Laboratory measurement of serum NT-proBNP level in pg/ml

Trial Locations

Locations (1)

Central Warsaw Medical University Teaching Hospital

🇵🇱

Warsaw, Mazowieckie, Poland

© Copyright 2025. All Rights Reserved by MedPath